About: Antivirals for Respiratory Viral Infections: Problems and Prospects

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Antivirals for Respiratory Viral Infections: Problems and Prospects Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Antivirals for Respiratory Viral Infections: Problems and Prospects
Creator	Liu, Qiang Yang, Zhan-Qiu Zhou, Yuan-Hong Feng Ye, Ã
Source	Medline; PMC
abstract	In the past two decades, several newly emerging and reemerging viral respiratory pathogens including several influenza viruses (avian influenza and pandemic influenza), severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV), have continued to challenge medical and public health systems. Thereafter, the development of cost-effective, broad-spectrum antiviral agents is the urgent mission of both virologists and pharmacologists. Current antiviral developments have focused targets on viral entry, replication, release, and intercellular pathways essential for viral life cycle. Here, we review the current literature on challenges and prospects in the development of these antivirals.
has issue date	2016-08-01(xsd:dateTime)
bibo:doi	10.1055/s-0036-1584803
bibo:pmid	27486742
has license	no-cc
sha1sum (hex)	aa835a556d0f46f7fd6da2e3f196e5a6832d3bba
schema:url	https://doi.org/10.1055/s-0036-1584803
resource representing a document's title	Antivirals for Respiratory Viral Infections: Problems and Prospects
has PubMed Central identifier	PMC7171711
has PubMed identifier	27486742
schema:publication	Semin Respir Crit Care Med
resource representing a document's body	covid:aa835a556d0f46f7fd6da2e3f196e5a6832d3bba#body_text
is schema:about of	named entity 'protease inhibitor' named entity 'human health' named entity 'oligonucleotides' named entity 'antivirals' named entity 'antigen detection' named entity 'influenza' named entity 'ACE2' named entity 'exportin' named entity 'avian influenza viruses' named entity 'virus replication' named entity 'respiratory viral infections' named entity 'H7N9' named entity 'influenza virus' named entity 'mice' named entity 'placebo group' named entity 'nucleus' named entity 'H1N1' named entity 'antiviral therapies' named entity 'antiviral activity' named entity 'sialic acid' named entity 'NAAT' named entity 'IC50' named entity 'leptomycin' named entity 'prophylactic' named entity 'uracil' named entity 'palivizumab' named entity 'influenza' named entity 'Cytochalasin' named entity 'host cells' named entity 'avian influenza virus' named entity 'receptor tyrosine kinases' named entity 'endosomal' named entity 'endosomes' named entity 'small-molecule' named entity 'HIV-1' named entity 'ribavirin' named entity 'RNA polymerase' named entity 'polymerase' named entity 'control group' named entity 'influenza virus' named entity 'wild type' named entity 'human influenza' named entity 'vRNP' named entity 'H5N1' named entity 'cellular membrane' named entity 'epizootic' named entity 'EGCG' named entity 'endosome' named entity 'influenza virus' named entity 'enzyme' named entity 'vacuolar' named entity 'avian influenza viruses' named entity 'nucleus' named entity 'Middle East respiratory syndrome coronavirus' named entity 'H3N2' named entity 'influenza virus' named entity 'respiratory syncytial viruses' named entity 'viruses' named entity 'virus infection' named entity 'adenovirus' named entity 'transmissibility' named entity 'viral shedding' named entity 'nucleic acids' named entity 'nitazoxanide' named entity 'vacuolar ATPase' named entity 'virus' named entity 'Cyclosporin A' named entity 'HCV' named entity 'clinical development' named entity 'clinical symptoms' named entity 'virus' named entity 'antiviral agents' named entity 'Crm1' named entity 'BCX4430' named entity 'influenza virus' named entity 'virus' named entity 'influenza virus' named entity 'membrane curvature'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software